Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuing to struggle with the term "harm reduction".

S T Higgins1

  • 1College on Problems of Drug Dependence and Department of Psychiatry, University of Vermont, Burlington, Vermont, USA. stephen.higgins@uvm.edu

Clinical Pharmacology and Therapeutics
|March 20, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Adherence Among Vulnerable Populations of Adults Assigned to Smoke Very Low Nicotine Content Cigarettes.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2022
Same author

Trend differences in men and women in rural and urban U.S. settings.

Preventive medicine·2018
Same author

A growing geographic disparity: Rural and urban cigarette smoking trends in the United States.

Preventive medicine·2017
Same author

The influence of Kantor's interbehavioral psychology on behavior analysis.

The Behavior analyst·2012
Same author

Comments on cognitive science in the experimental analysis of behavior.

The Behavior analyst·2012
Same author

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.

Drug and alcohol dependence·2002
Same journal

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

Clinical pharmacology and therapeutics·2026
Same journal

Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

Clinical pharmacology and therapeutics·2026
Same journal

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Clinical pharmacology and therapeutics·2026
Same journal

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

Clinical pharmacology and therapeutics·2026
Same journal

Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused Registries.

Clinical pharmacology and therapeutics·2026
Same journal

Quantitative Systems Toxicology Model Predicts Obeticholic Acid-Associated Liver Injury in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Clinical pharmacology and therapeutics·2026
See all related articles

The author agrees with expunging "harm reduction" from professional lexicons. However, the focus is on managing existing literature and activities associated with the term.

Area of Science:

  • Public Health
  • Medical Terminology

Background:

  • Alan Leshner's commentary recommends removing the term "harm reduction" from professional lexicons.
  • This perspective acknowledges the validity of Leshner's recommendation.

Discussion:

  • The commentary addresses the practical challenge of dealing with the extensive existing body of literature and ongoing activities related to "harm reduction."
  • It proposes a strategic approach to manage this established corpus.

Key Insights:

  • Agreement exists on the potential benefits of removing "harm reduction" from professional discourse.
  • The primary challenge lies in the practical management of existing resources and practices.

Outlook:

  • Future efforts should focus on developing strategies for reclassifying or contextualizing existing "harm reduction" literature.

Related Experiment Videos

  • This involves addressing the legacy of the term while potentially adopting new terminology.